SETMAR and cancer: Dysregulation of SETMAR expression has been associated with several cancers, including glioblastoma, leukemia, hematologic neoplasms, breast and colon cancer, and mantle cell lymphoma (Figure 6B) [16,22,23,24,25,26,27,28,29,30].